377 related articles for article (PubMed ID: 36868481)
21. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
[TBL] [Abstract][Full Text] [Related]
22. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
Grimsrud MM; Folseraas T
Liver Int; 2019 Dec; 39(12):2230-2237. PubMed ID: 31216595
[TBL] [Abstract][Full Text] [Related]
24. Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis.
Saca D; Flamm SL
Clin Liver Dis; 2024 Feb; 28(1):183-192. PubMed ID: 37945159
[TBL] [Abstract][Full Text] [Related]
25. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
[TBL] [Abstract][Full Text] [Related]
26. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
Quinn KP; Tabibian JH; Lindor KD
Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
[TBL] [Abstract][Full Text] [Related]
28. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
29. Outruling cholangiocarcinoma in patients with primary sclerosing cholangitis wait-listed for liver transplantation: A report on the Irish national experience.
Duggan WP; Brosnan C; Christodoulides N; Nolan N; Kambakamba P; Gallagher TK
Surgeon; 2023 Apr; 21(2):e83-e88. PubMed ID: 35680491
[TBL] [Abstract][Full Text] [Related]
30. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
Bergquist A; Glaumann H; Persson B; Broomé U
Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
[TBL] [Abstract][Full Text] [Related]
31. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis.
Saffioti F; Roccarina D; Vesterhus M; Hov JR; Rosenberg W; Pinzani M; Pereira SP; Boberg KM; Thorburn D
Eur J Clin Invest; 2019 May; 49(5):e13088. PubMed ID: 30762236
[TBL] [Abstract][Full Text] [Related]
32. Recall processes for biliary cytology in primary sclerosing cholangitis.
Eaton JE; Gossard AA; Talwalkar JA
Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
[TBL] [Abstract][Full Text] [Related]
33. Cholangiocarcinoma in patients with primary sclerosing cholangitis.
Fung BM; Tabibian JH
Curr Opin Gastroenterol; 2020 Mar; 36(2):77-84. PubMed ID: 31850928
[TBL] [Abstract][Full Text] [Related]
34. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
[TBL] [Abstract][Full Text] [Related]
35. Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data.
Hu C; Iyer RK; Juran BD; McCauley BM; Atkinson EJ; Eaton JE; Ali AH; Lazaridis KN
BMC Gastroenterol; 2023 Apr; 23(1):129. PubMed ID: 37076803
[TBL] [Abstract][Full Text] [Related]
36. Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL-17A.
Lieshout R; Kamp EJCA; Verstegen MMA; Doukas M; Dinjens WNM; Köten K; IJzermans JNM; Bruno MJ; Peppelenbosch MP; van der Laan LJW; de Vries AC
Int J Cancer; 2023 Jun; 152(12):2607-2614. PubMed ID: 36346104
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of cholangiocarcinoma.
Bergquist A; von Seth E
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
[TBL] [Abstract][Full Text] [Related]
38. Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis.
Eaton JE; Welle CL; Bakhshi Z; Sheedy SP; Idilman IS; Gores GJ; Rosen CB; Heimbach JK; Taner T; Harnois DM; Lindor KD; LaRusso NF; Gossard AA; Lazaridis KN; Venkatesh SK
Hepatology; 2021 May; 73(5):1868-1881. PubMed ID: 32974892
[TBL] [Abstract][Full Text] [Related]
39. Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.
Lee JJ; Schindera ST; Jang HJ; Fung S; Kim TK
Abdom Radiol (NY); 2017 Dec; 42(12):2898-2908. PubMed ID: 28951947
[TBL] [Abstract][Full Text] [Related]
40. Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis.
Tabibian JH; Enders F; Imam MH; Kolar G; Lindor KD; Talwalkar JA
Ann Hepatol; 2014; 13(3):384-9. PubMed ID: 24756015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
